Spanish Ovarian Cancer Research Group

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote et al. · New England Journal of Medicine · 2019 · 2.1K citations · Full text

Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

Mariano Provencio, Ernest Nadal, Amelia Insa et al. · The Lancet Oncology · 2020 · 788 citations

Medicine, Immune Checkpoint Inhibitor, Cancer Treatment +4

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer

Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant et al. · International Journal of Gynecological Cancer · 2015 · 745 citations · Full text

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

Andreas du Bois, Michael Quinn, Tate Thigpen et al. · Annals of Oncology · 2005 · 465 citations

Medicine, Cancer Management, Reproductive Health +9

β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

Stephan P. Tenbaum, Paloma Ordóñez‐Morán, Isabel Puig et al. · Nature Medicine · 2012 · 395 citations · Full text

Subverts Foxo3a, Oncology, Medicine +10